Esthesioneuroblastoma screening: Difference between revisions
Jump to navigation
Jump to search
Simrat Sarai (talk | contribs) (Created page with "__NOTOC__ {{Esthesioneuroblastoma}} {{CMG}}{{AE}}{{Simrat}} ==Overview== According to the United States Preventive Services Task Force, screening for esthesioneuroblastoma is...") |
Simrat Sarai (talk | contribs) No edit summary |
||
Line 8: | Line 8: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Line 15: | Line 13: | ||
[[Category:neurology]] | [[Category:neurology]] | ||
[[Category:Rhinology]] | [[Category:Rhinology]] | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 06:52, 27 January 2016
Esthesioneuroblastoma Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Esthesioneuroblastoma screening On the Web | |
American Roentgen Ray Society Images of Esthesioneuroblastoma screening | |
Risk calculators and risk factors for Esthesioneuroblastoma screening | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
According to the United States Preventive Services Task Force, screening for esthesioneuroblastoma is not recommended.[1]
Screening
According to the United States Preventive Services Task Force, screening for esthesioneuroblastoma is not recommended.[1]
References
- ↑ 1.0 1.1 http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=esthesioneuroblastoma Accessed on December 26, 2016.